CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals

This publication has 52 references indexed in Scilit:

• HLA‐Bw4Homozygosity Is Associated with an Impaired CD4 T Cell Recovery after Initiation of Antiretroviral Therapy
  Clinical Infectious Diseases, 2008
• Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort
  PLOS ONE, 2006
• Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection
  PLoS Medicine, 2006
• Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response
  AIDS, 2006
• Influence of Host Genetic Variation on Susceptibility to HIV Type 1 Infection
  The Journal of Infectious Diseases, 2005
• The Case for Earlier Treatment of HIV Infection
  Clinical Infectious Diseases, 2004
• T Cell Dynamics in HIV-1 Infection
  Annual Review of Immunology, 2003
• Concordance between the CC Chemokine Receptor 5 Genetic Determinants That Alter Risks of Transmission and Disease Progression in Children Exposed Perinatally to Human Immunodeficiency Virus
  The Journal of Infectious Diseases, 2001
• Sustained CD4⁺T Cell Response after Virologic Failure of Protease Inhibitor–Based Regimens in Patients with Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2000
• Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection
  AIDS, 1998